Weight-loss giant Novo Nordisk's shares rose over 5% on Friday to a high last touched in October, driven by "encouraging" ...

Abstract "Double-extortion" ransomware attacks not only encrypt systems but also steal sensitive data. Traditional backups ...

Relationships form through memories filled with emotion and images. When a relationship ends, we might wonder why our thoughts seem cloudy. Loss and grief, from many circumstances, can cause cognitive ...

BIRMINGHAM, Ala.–– The first half of Saturday night's matchup between No. 12 Alabama and No. 1 Arizona was everything a college basketball fan could ask for in a top-15 matchup. The atmosphere inside ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Eli Lilly (LLY) shares spiked ~3% on Thursday after the obesity drugmaker posted Phase 3 data showing its next-gen therapy retatrutide can generate up to 24% of weight loss, a “best-in-class" efficacy ...

Chongwei Chen is the President & CEO of DataNumen, a global data recovery leader with solutions trusted by Fortune 500 companies worldwide. With artificial intelligence becoming deeply integrated in ...

Ascletis Pharma Inc. shares surged Tuesday, posting their biggest rally since April, after mid-stage results for its oral weight-loss drug suggested a potential best-in-class profile. The highest dose ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

HOUSTON (KTRK) -- Using HISD data obtained through a source within the district, Eyewitness News has learned that the majority of the 2025-26 enrollment drop came from the district's New Education ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.